Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2012, Article ID 453985, 8 pages
http://dx.doi.org/10.1155/2012/453985
Research Article

Racial Differences in the Use of Adjuvant Chemotherapy for Breast Cancer in a Large Urban Integrated Health System

1Department of Oncology, Karmanos Cancer Institute, Wayne State University, 4100 John Road, 4221 HWCRC Detroit, MI 48201, USA
2Population Studies and Disparities Research Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
3Department of Public Health Sciences, Henry Ford Health Systems, Detroit, MI 48202, USA
4Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, MI 48201, USA
5Wayne State University School of Medicine, Detroit, MI 48201, USA

Received 6 January 2012; Revised 18 March 2012; Accepted 19 March 2012

Academic Editor: Wonshik Han

Copyright © 2012 Michael S. Simon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Candyce H. Kroenke, Carol Sweeney, Marilyn L. Kwan, Charles P. Quesenberry, Erin K. Weltzien, Laurel A. Habel, Adrienne Castillo, Phillip S. Bernard, Rachel E. Factor, Lawrence H. Kushi, and Bette J. Caan, “Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Molly E. Roseland, Mary E. Pressler, Lois E. Lamerato, Rick Krajenta, Julie J. Ruterbusch, Jason C. Booza, Kendra Schwartz, and Michael S. Simon, “Racial differences in breast cancer survival in a large urban integrated health system,” Cancer, 2015. View at Publisher · View at Google Scholar
  • Kendra Schwartz, Julie J. Ruterbusch, Joanne S. Colt, David C. Miller, Wong-Ho Chow, and Mark P. Purdue, “Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors,” Cancer Medicine, 2015. View at Publisher · View at Google Scholar
  • Angela Gabrielly Quirino Freitas, and Mathias Weller, “Patient delays and system delays in breast cancer treatment in developed and developing countries,” Ciencia & Saude Coletiva, vol. 20, no. 10, pp. 3177–3189, 2015. View at Publisher · View at Google Scholar
  • Melissa J. Edwards, Ian D. Campbell, Ross A. Lawrenson, and Marion J. Kuper-Hommel, “Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis,” Breast Cancer Research and Treatment, 2017. View at Publisher · View at Google Scholar
  • M. E. Roseland, K. Schwartz, J. J. Ruterbusch, L. Lamerato, R. Krajenta, J. Booza, and Michael S. Simon, “Influence of clinical, societal, and treatment variables on racial differences in ER−/PR− breast cancer survival,” Breast Cancer Research and Treatment, 2017. View at Publisher · View at Google Scholar
  • Lei Chen, Belen San Antonio, Yu Yan, Jian Chen, Robert J. Goodloe, and William J. John, “Safety profiles of non-small cell lung cancer patients treated with pemetrexed plus carboplatin: a real-world retrospective, observational, cohort study,” Current Medical Research and Opinion, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  • Xiaofang He, Fen Ye, Bingcheng Zhao, Hailin Tang, Jin Wang, Xiangsheng Xiao, and Xiaoming Xie, “Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients,” Plos One, vol. 12, no. 3, pp. e0173862, 2017. View at Publisher · View at Google Scholar